Dermatosis del embarazo

Autores/as

  • Alexandra Llanos Universidad del Valle

Resumen

El embarazo es una condición que altera el funcionamiento metabólico, endocrino e inmunológico en las pacientes y, como consecuencia de ello, pueden aparecer cambios fisiológicos en la piel, enfermedades propias de la gestación y las enfermedades preexistentes pueden cambiar su comportamiento. El objetivo de esta revisión es actualizar los conceptos sobre estas entidades, su patogenia y manejo.

Biografía del autor/a

Alexandra Llanos, Universidad del Valle

Residente 11! Dermatología, Universidad del Valle, Cali, Colombia.

Referencias bibliográficas

1. Muzzafar et al. Physiologic skin changes during pregnancy: a study of 140 cases. lnt J Dermatol 1998; 37:429-431.
https://doi.org/10.1046/j.1365-4362.1998.00281.x

2. BrennerM. Dermatologic diseases and problems of women throughout the lite cycle. lnt J Dermatol 1995; 34:369-379.
https://doi.org/10.1111/j.1365-4362.1995.tb04434.x

3. Klippengerger S. Quantification of tyrosinase, TRP- 1, and TRP-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR­ regulation by steroid hormones. J lnvest Dermatol 1998; 110:364-367.
https://doi.org/10.1038/jid.1998.1

4. Reish O. Spontaneous hair hyperpigmentation in response to vitamine intake in pregnancy, a clue for homocystinuria. Am J Obst Gynecol 1995; 173:1648-1651.
https://doi.org/10.1016/0002-9378(95)90677-0

5. Wallace J. Estrogen and progesterone receptors in androgenic alopecia vs alopecia areata. Am J Dermatopathol 1998; 20:160-163.
https://doi.org/10.1097/00000372-199804000-00010

6. F ryer J et al. Pregnancy associate hyperpigmentation: longitudinal melanonychia. JAAD 1992; 26: 493-494.
https://doi.org/10.1016/S0190-9622(08)80582-8

7. Pribanich M. Low-dose tretinoin does not improve striae distensae: a double-blind, placebo-controlled study. Cutis 1994; 54:121-124.

8. Lee K et al. Decreased expression of collagen and fibronectin genes in striae distensae tissue. Clin Exp Dermatol 1994; 19:285-288.
https://doi.org/10.1111/j.1365-2230.1994.tb01196.x

9. Kang H. Topical tretinoin therapy for management of early striae. J Am Acad Dermatol 1998; 39:S90-92.
https://doi.org/10.1016/S0190-9622(98)70453-0

10. Alster TS. Laser treatment of hypertrophic scars, keloids, and striae. Dermatol Clin 1997; 15:419-429.
https://doi.org/10.1016/S0733-8635(05)70451-4

11. McDaniel A. Treatment of stretch marks with the 585- nm flashlamp-pumped dye laser. Dermatol Surg 1996; 22:332-337.
https://doi.org/10.1111/j.1524-4725.1996.tb00326.x

12. Ash L. Comparison of topical therapy for striae alba (20% glycolic acid/0.05% tretinoin vs. 20% glycolic acid/10% L-ascorbic acid). Dermatol Surg 1998; 24:849-856.
https://doi.org/10.1111/j.1524-4725.1998.tb04262.x

13. ShornickJ.Dermatosis of pregnancy. SeminCutan Med Surg 1998; 17:172-181.
https://doi.org/10.1016/S1085-5629(98)80011-4

14. Kim Y. Herpes gestationis. Dermatol Clin 1990; 8:727- 735.
https://doi.org/10.1016/S0733-8635(18)30459-5

15. Shornick J. Herpes gestationis. Dermatol Clin 1993; 11:527-532.
https://doi.org/10.1016/S0733-8635(18)30248-1

16. Mascaró Jr et al. Fetal morbidity in herpes gestationis. Arch Dermatol 1995; 131:1209-121O.
https://doi.org/10.1001/archderm.1995.01690220117027

17. lbbotson E. An uninvolved pregnancy in a patient alter a previous episode of herpes gestationis. Arch Dermatol 1995; 131:1091-1092.
https://doi.org/10.1001/archderm.1995.01690210123027

18. Caproni et al. Serum eosinophil cationic protein (ECP) in bullous pemphigoid. lnt J Dermatol 1995; 34:177-180.
https://doi.org/10.1111/j.1365-4362.1995.tb01562.x

19. Bedane D. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J lnvest Dermatol 1997; 108:901-907.
https://doi.org/10.1111/1523-1747.ep12292701

20. Paternoster l. New observations on herpes gestationis theraphy. lnt J Gynecol & Obst 1997; 56:277-278.
https://doi.org/10.1016/S0020-7292(96)02839-1

21. Henry et al. Striae distensae of pregnancy. An in vivo biomechanical evaluation. lnt J Dermatol 1997; 36:448-450.
https://doi.org/10.1046/j.1365-4362.1997.00041.x

22. Esteve F. Facial involvement in papulous, prurient and urticaria! skin disease in pregnancy. Ann Derm Vener 1996; 123:122-123.

23. Aronson l. Pruritic urticaria! papules and plaques of pregnancy: clinical and immunopathologic observa- tions in 57 patients. JAAD 1998; 39:933-939.
https://doi.org/10.1016/S0190-9622(98)70265-8

24. Nicastri PL. A randomised placebo-controlled trial of ursadeoxycholic acid and S-adenosyl methionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynecol 1998; 105:1205-1207.
https://doi.org/10.1111/j.1471-0528.1998.tb09976.x

25. Borradori L. lgM autoantibodies to 80-and 230- to 240-kd human epidermal proteins in pregnancy. Arch Dermatol 1995; 131:43-47.
https://doi.org/10.1001/archderm.1995.01690130045008

26. Avril MF. Melanoma, hormonal factors and pregnancy. Ann Derm Vener 1993; 120:919-925 .

27. Pennoyer J. Changes in size of melanocytic nevi during pregnancy. JAAD 1997; 36:378-382.
https://doi.org/10.1016/S0190-9622(97)80212-5

28. Ellis D. Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndro- me. JAAD 1991; 25:467-482.
https://doi.org/10.1016/0190-9622(91)70227-S

29. Brenner N. Dermatologic diseases and problems of women throughout the lite cycle. lnt J Dermatol 1995; 34:369-379.
https://doi.org/10.1111/j.1365-4362.1995.tb04434.x

30. Grin C. The relationship of pregnancy, hormones, and melanoma. Semin Cutan Med Surg 1998; 17:167-171.
https://doi.org/10.1016/S1085-5629(98)80010-2

31. Squatrito R. Melanoma complicating pregnancy. Obst Gynecol Clin North Am 1998; 25:407-416.
https://doi.org/10.1016/S0889-8545(05)70014-0

32. Alpsoy E. Hyperkeratosis of the nipple: report of two cases. J Dermatol 1997; 24:43-45.
https://doi.org/10.1111/j.1346-8138.1997.tb02737.x

33. Park B, Youn J. Factors influencing psoriasis: an analysis based upon the extent of involvement and clinical type. J Dermatol 1998; 25:97-102.
https://doi.org/10.1111/j.1346-8138.1998.tb02357.x

34. Mowad C. Hormonal influences in women with psoriasis. Cutis 1998; 61:257-260.

35. Rodríguez G, Orozco L. Lepra 1996; 113-115.

36. Lyde CB. Pregnancy in patients with Hansen's disease. Arch Dermatol 1997; 133:623-627.
https://doi.org/10.1001/archderm.1997.03890410079010

37. García E. lmmunology of the cutaneous disorders of pregnancy. lnt J Dermatol 1999; 38:721-729.
https://doi.org/10.1046/j.1365-4362.1999.00810.x

38. Nelson JL. Microchimerism and autoinmune diseases. New Engl J Med 1998; 338: 1224-1225.
https://doi.org/10.1056/NEJM199804233381711

39. Nelson L. Pregnancy immunology and autoimmune disease. J Reprod Med 1998; 43:335-339.

Cómo citar

1.
Llanos A. Dermatosis del embarazo. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de junio de 2000 [citado 28 de marzo de 2024];8(2):163-72. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/685

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2000-06-01

Cómo citar

1.
Llanos A. Dermatosis del embarazo. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de junio de 2000 [citado 28 de marzo de 2024];8(2):163-72. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/685

Número

Sección

Sin sección en el original